Evidence map›Paper›PMID 39334686›Full record

ReviewAntioxidants (Basel, Switzerland)2024

Metabolic and Biochemical Effects of Pyrroloquinoline Quinone (PQQ) on Inflammation and Mitochondrial Dysfunction: Potential Health Benefits in Obesity and Future Perspectives.

Davide Charrier, Giuseppe Cerullo, Roberta Carpenito, Vincenzo Vindigni, Franco Bassetto, Luca Simoni, Tatiana Moro, Antonio Paoli

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Effects of dietary PQQ·NaPoultry science · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Davide CharrierDepartment of Biomedical Sciences, University of Padova, 35122 Padua, Italy.ORCID 0009-0001-4081-4565
Giuseppe CerulloDepartment of Biomedical Sciences, University of Padova, 35122 Padua, Italy.ORCID 0000-0001-8098-2283
Roberta CarpenitoPlastic and Reconstructive Surgery Unit, Department of Neurosciences, University of Padua, 35122 Padua, Italy.
Vincenzo VindigniPlastic and Reconstructive Surgery Unit, Department of Neurosciences, University of Padua, 35122 Padua, Italy.ORCID 0000-0001-6638-9010
Franco BassettoPlastic and Reconstructive Surgery Unit, Department of Neurosciences, University of Padua, 35122 Padua, Italy.
Luca SimoniDepartment of Biomedical Sciences, University of Padova, 35122 Padua, Italy.
Tatiana MoroDepartment of Biomedical Sciences, University of Padova, 35122 Padua, Italy.ORCID 0000-0002-1404-1511
Antonio PaoliDepartment of Biomedical Sciences, University of Padova, 35122 Padua, Italy.ORCID 0000-0003-0474-4229

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is defined as a complex, systemic disease characterized by excessive and dysfunctional adipose tissue, leading to adverse health effects. This condition is marked by low-grade inflammation, oxidative stress, and metabolic abnormalities, including mitochondrial dysfunction. These factors promote energy dysregulation and impact body composition not only by increasing body fat but also by promoting skeletal muscle mass atrophy. The decline in muscle mass is associated with an increased risk of all-cause mortality in individuals with this disease. The European Food Safety Authority approved pyrroloquinoline quinone (PQQ), a natural compound, as a dietary supplement in 2018. This narrative review aims to provide a comprehensive overview of the potential role of PQQ, based on its anti-inflammatory and antioxidant properties, in addressing dysfunctional adipose tissue metabolism and related disorders.

Indexed as

adipose tissueinflammationmitochondrial dysfunctionoxidative stresspyrroloquinoline quinone (PQQ)

Identifiers

PMID39334686
PMCPMC11429417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.